CCJ vs NXE: How Cameco and NexGen Energy Compare (2026)

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CCJ and NXE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CCJ and NXE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Cameco (CCJ) is one of the world's largest publicly traded uranium producers and a major supplier of nuclear fuel. Based in Saskatchewan, Canada, it mines uranium from some of the highest-grade deposits in the world, including the Cigar Lake and McArthur River operations, and sells uranium concentrate (U3O8) to utilities that run nuclear power plants. Beyond mining, Cameco participates across the nuclear fuel cycle through refining, conversion, and fuel-fabrication activities, and it holds a significant interest in Westinghouse, a leading provider of nuclear reactor technology and services, acquired alongside Brookfield. Cameco's revenue is tied to long-term contracts with utilities and to uranium spot and contract prices, which are driven by global nuclear power demand, supply discipline, and the broader case for clean, baseload electricity. It trades on the New York Stock Exchange and the Toronto Stock Exchange.

Full CCJ guide

NexGen Energy (NXE) is a Canadian uranium development company advancing the Rook I project in the Athabasca Basin of Saskatchewan, one of the highest-grade uranium districts in the world. Its flagship Arrow deposit is among the largest undeveloped high-grade uranium resources globally. NexGen is a pre-production developer: it is working through permitting, federal and provincial environmental approvals, and project financing toward a construction decision, rather than mining and selling uranium today. The investment case is leveraged to the price of uranium and to the company successfully permitting, financing, and building a large mine on schedule and on budget. NexGen is dual-listed, trading on the New York Stock Exchange and the Toronto Stock Exchange, and is followed closely by investors betting on a nuclear-energy and uranium-supply revival. Because it does not yet generate meaningful revenue from production, it carries the elevated risk profile typical of a single-asset mining developer.

Full NXE guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CCJ drivers: Nuclear demand and the clean-energy case; Uranium supply discipline and pricing.
• NXE drivers: World-class Athabasca asset; Nuclear revival and uranium demand.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Cameco's results are tied to volatile uranium prices and to global nuclear power sentiment, which can swing on policy and on high-profile events. For NXE, nexGen is pre-revenue and depends on a single project, so it carries concentrated development risk: permitting delays, cost overruns, construction execution, and the need to raise large amounts of capital, which can dilute existing shareholders.

Pick CCJ if you believe its drivers more; NXE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CCJ and NXE guides.

CCJ. Cameco often trades on a high or volatile price-to-earnings multiple because its earnings swing with uranium prices and reflect the Westinghouse investment. Investors typically value it on the long-term uranium demand and supply outlook and on its contracted sales book rather than on a single year of earnings. All figures are approximate and move with uranium prices and the share price; verify current numbers before relying on them.

NXE. As a pre-production developer, NexGen cannot be valued on current earnings; the market prices it on the project's resource value, expected economics, the uranium price, and the probability of permitting, financing, and building the mine. This makes traditional P/E meaningless and the stock highly speculative and volatile. All figures are approximate and should be verified against the latest filings and technical reports.

Headline figures (approximate, early 2026): CCJ shows revenue (ttm) ~$2-3 billion (approximate, verify), primary product Uranium concentrate (U3O8), key assets Cigar Lake, McArthur River; ~49% Westinghouse stake (verify), p/e (ttm) Elevated and volatile (commodity earnings; approximate, verify); NXE shows stage Pre-production development (no meaningful production revenue), flagship project Rook I / Arrow deposit, Athabasca Basin, Saskatchewan, Canada, revenue (ttm) Minimal to none from production (approximate, verify), earnings Typically operating losses as a developer (approximate, verify).

CCJ and NXE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CCJ and NXE exposure against your real portfolio. It is not an investment adviser.